First Pass

4 stories from 3 sources

Wednesday, June 17, 2026

Day’s Recap is unavailable for this topic and date. Feel free to go through our curated list of stories below.

Other Developments

A curated list of other prominent stories from this day.

11:01 AMPackaging Dive

Scaling reusable packaging systems in Portland, Oregon

Summary

A coalition of local businesses, nonprofits, and government groups is building reusable packaging and foodservice-container systems across the Portland region. The work positions Portland as a leading US market for reuse by coordinating pilots, operations, and adoption across stakeholders.

Why it matters

Reusable packaging only reduces waste when collection and cleaning work like a utility, and Portland is testing what it takes to build that utility.

10:31 AMPackaging Dive

30 by ‘30: Bold Reuse details strategies to scale reusables systems in US

Summary

Bold Reuse, about two years after reaching profitability, is expanding its reusable packaging operations by adding partners and entering new metropolitan markets. The company says extended producer responsibility laws are accelerating demand for reuse systems.

Why it matters

Regulation-backed reuse can rewire packaging supply chains, creating new operational requirements and cost structures for brands and their logistics partners.

6:54 AMThe New York Times

Japan Raids Ice Cream Giants in Cartel Investigation

Summary

Japan’s Fair Trade Commission raided six major ice cream makers, saying it suspects they coordinated to fix prices on widely sold frozen products. The investigation targets alleged collusion that may have shaped retail pricing across the category.

Why it matters

A cartel probe in a staple consumer category can quickly ripple through supplier contracts, retailer pricing, and inflation optics.

1:15 AMBloomberg Markets

GLP-1 Craze Fuels Protein-Powder Maker Glanbia’s Share Rally

Summary

Rising use of GLP-1 weight loss drugs is lifting demand for protein supplements, benefiting Glanbia’s nutrition business. Investors are bidding up Glanbia shares on expectations that this demand tailwind will persist.

Why it matters

GLP-1 drugs are now a demand signal that can rewire nutrition supply chains and reprice winners and losers across food, ingredients, and consumer health.

Make it yours

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!